Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients

doi:10.1097/TP.0000000000003850

Comparative Study

. 2021 Aug 1;105(8):e82-e83.

doi: 10.1097/TP.0000000000003850.

Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients

Brian J Boyarsky¹, Teresa P-Y Chiang¹, Michael T Ou¹, William A Werbel², Allan B Massie¹, Dorry L Segev^{1

3}, Jacqueline M Garonzik-Wang¹

Affiliations

¹ Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
² Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
³ Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.

PMID: 34098566
PMCID: PMC8298284
DOI: 10.1097/TP.0000000000003850

Comparative Study

Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients

Brian J Boyarsky et al. Transplantation. 2021.

. 2021 Aug 1;105(8):e82-e83.

doi: 10.1097/TP.0000000000003850.

Authors

Brian J Boyarsky¹, Teresa P-Y Chiang¹, Michael T Ou¹, William A Werbel², Allan B Massie¹, Dorry L Segev^{1

3}, Jacqueline M Garonzik-Wang¹

Affiliations

¹ Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
² Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
³ Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.

PMID: 34098566
PMCID: PMC8298284
DOI: 10.1097/TP.0000000000003850

No abstract available

PubMed Disclaimer

Conflict of interest statement

D.L.S. received consulting and speaking honoraria from Sanofi, Novartis, CSL Behring, Jazz Pharmaceuticals, Veloxis, Mallinckrodt, Thermo Fisher Scientific. The remaining authors of this manuscript have no financial disclosures or conflicts of interest to disclose as described by Transplantation.

Figures

**Figure 1.**
SARS-CoV-2 Anti-Receptor Binding Domain Antibody Titers Among Recipients of mRNA versus Janssen Vaccine.

See this image and copyright information in PMC

Cited by

Effects of Anti-COVID-19 Vaccination and Pre-Exposure Prophylaxis with Tixagevimab-Cilgavimab in Kidney and Liver Transplant Recipients.
Angelico R, Romano F, Coppola L, Materazzo M, Pedini D, Santicchia MS, Cacciola R, Toti L, Sarmati L, Tisone G. Angelico R, et al. Medicina (Kaunas). 2023 Nov 30;59(12):2101. doi: 10.3390/medicina59122101. Medicina (Kaunas). 2023. PMID: 38138204 Free PMC article.
High Rate of Antibody Response to Multiple Doses of the COVID-19 Vaccine in Liver Transplant Recipients: Analysis of Predictive Factors.
Zignani N, Costantino A, Sagasta M, Dibenedetto C, Perbellini R, Uceda Renteria S, Lampertico P, Donato MF. Zignani N, et al. Vaccines (Basel). 2025 Mar 26;13(4):352. doi: 10.3390/vaccines13040352. Vaccines (Basel). 2025. PMID: 40333209 Free PMC article.
Humoral response to different SARS-CoV-2 vaccines in orthotopic liver transplant recipients.
Toapanta-Yanchapaxi L, Chiquete E, Ávila-Rojo E, López-Yánez S, Luna Del Villar Velasco S, Rivera Monroy S, López Gómez T, Andrés Aguilar JB, Balcázar Antonio DF, Alcaraz-Fuerte C, García Baysa M, López Jiménez JL, Márquez-Guillén E, Vilatobá M, Cruz-Martínez R, Carpinteyro-Espin P, Chávez-Villa M, Romero Morelos RD, Torres-Del Real D, Uscanga-Domínguez LF, García-Alanis M, Tapia Sosa R, Servín-Rojas M, Valdez-Echeverria RD, García-Juárez I. Toapanta-Yanchapaxi L, et al. Vaccine. 2022 Sep 9;40(38):5621-5630. doi: 10.1016/j.vaccine.2022.08.027. Epub 2022 Aug 22. Vaccine. 2022. PMID: 36028456 Free PMC article.
Development of T follicular helper cell-independent nanoparticle vaccines for SARS-CoV-2 or HIV-1 by targeting ICOSL.
Zhang Y, Chen A, Li D, Yuan Q, Zhu A, Deng J, Wang Y, Liu J, Liang C, Li W, Fang Q, Xie J, Zhang X, Zhang X, Zhang Y, Chen R, Pan T, Zhang H, He X. Zhang Y, et al. NPJ Vaccines. 2024 Sep 28;9(1):176. doi: 10.1038/s41541-024-00971-4. NPJ Vaccines. 2024. PMID: 39341822 Free PMC article.
A Call for Caution in the Immunocompromised: Coronavirus Disease 2019 Associated With Mortality in a Vaccinated Lung Transplant Recipient.
Hogan JI, Kotton CN. Hogan JI, et al. Open Forum Infect Dis. 2021 Nov 10;8(12):ofab557. doi: 10.1093/ofid/ofab557. eCollection 2021 Dec. Open Forum Infect Dis. 2021. PMID: 34988243 Free PMC article.

See all "Cited by" articles

References

1. Sadoff J, Le Gars M, Shukarev G, Heerwegh D, Truyers C, de Groot AM, et al. Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine. New England Journal of Medicine. 2021. - PMC - PubMed
1. Custers J, Kim D, Leyssen M, Gurwith M, Tomaka F, Robertson J, et al. Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment. Vaccine. 2020. - PMC - PubMed
1. Stephenson KE, Le Gars M, Sadoff J, de Groot AM, Heerwegh D, Truyers C, et al. Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19. JAMA. 2021;325(15):1535–44. - PMC - PubMed
1. Boyarsky BJ, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, et al. Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients. JAMA. 2021. - PMC - PubMed
1. Boyarsky BJ, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, et al. Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients. JAMA. 2021. - PMC - PubMed

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Sadoff J, Le Gars M, Shukarev G, Heerwegh D, Truyers C, de Groot AM, et al. Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine. New England Journal of Medicine. 2021. - PMC - PubMed

[2] Sadoff J, Le Gars M, Shukarev G, Heerwegh D, Truyers C, de Groot AM, et al. Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine. New England Journal of Medicine. 2021. - PMC - PubMed

[3] Custers J, Kim D, Leyssen M, Gurwith M, Tomaka F, Robertson J, et al. Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment. Vaccine. 2020. - PMC - PubMed

[4] Custers J, Kim D, Leyssen M, Gurwith M, Tomaka F, Robertson J, et al. Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment. Vaccine. 2020. - PMC - PubMed

[5] Stephenson KE, Le Gars M, Sadoff J, de Groot AM, Heerwegh D, Truyers C, et al. Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19. JAMA. 2021;325(15):1535–44. - PMC - PubMed

[6] Stephenson KE, Le Gars M, Sadoff J, de Groot AM, Heerwegh D, Truyers C, et al. Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19. JAMA. 2021;325(15):1535–44. - PMC - PubMed

[7] Boyarsky BJ, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, et al. Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients. JAMA. 2021. - PMC - PubMed

[8] Boyarsky BJ, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, et al. Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients. JAMA. 2021. - PMC - PubMed

[9] Boyarsky BJ, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, et al. Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients. JAMA. 2021. - PMC - PubMed

[10] Boyarsky BJ, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, et al. Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients. JAMA. 2021. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients

Affiliations

Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients

Authors

Affiliations

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Medical